Document is current
Any future updates will be listed below
-
Authors
Tovar-Ferrero, Oscar https://orcid.org/0009-0005-6959-7460
Rubio, Javier https://orcid.org/0000-0003-0320-5100
Zorzano, Antonio https://orcid.org/0000-0002-1638-0306
Martínez-Corrales, Guillermo https://orcid.org/0000-0002-3923-5902
Liesa, Marc https://orcid.org/0000-0002-5909-8570
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (PID2021-127278NB-I00)
Ministerio de Ciencia e Innovación (PID2023-146293NA-I00)
BBVA | Fundación BBVA (LEO22-2-1659-BBM-BIO-18.)
Consejo Superior de Investigaciones Científicas (Scientific Network Enfermedades Metabólicas)
- License Information
-
More Information
Article History
Received: 2 May 2025
Revised: 21 October 2025
Accepted: 22 October 2025
First Online: 17 November 2025
Disclosure and competing interests statement
: ML is a co-founder of Enspire Bio LLC, was a consultant for Capacity Bio and received sponsored research agreements from Bantam Pharmaceutical, Janssen, Amgen and Senergy Bio.
